Daryl Faulkner will take over as president and CEO of Digene, effective Dec. 11. He will also become a member of the diagnostic firm’s board of directors. Faulkner will succeed Evan Jones, a founder of Digene, who is retiring after 16 years with the firm.
Faulkner most recently served as senior vice president of global business segments at Invitrogen. He announced late last year that he was retiring from the firm. Faulkner spent eight years with Invitrogen in a number of senior level positions. Previous to Invitrogen, he worked for Abbott Laboratories for 15 years.
Sigma-Aldrich has elected Steven M. Paul to its board of directors. Paul is executive vice president for science and technology and president of the Lilly Research Laboratories of Eli Lilly.
NimbleGen Systems has named Gregory McGuinness as vice president of international business. McGuinness previously served as director of European business development for Gene Logic. He also has previously worked for Affymetrix, Stratagene, and Applied Biosystems.
Cellumen has appointed Lee Hood to its scientific advisory board, the company said last week. Hood is president of the Institute for Systems Biology in Seattle.
The European Molecular Biology Organization has announced new members including Ruedi Aebersold of the Institute of Molecular Systems Biology in Zurich, Switzerland; Jan Ellenberg of the European Microbiology Laboratory in Heidelberg, Germany; Lee Hood of the Institute for Systems Biology in Seattle; and Ulf Landegren of the Department of Genetics and Pathology at Uppsala University, Sweden.